RESUMEN
Radyosinovectomy (RSV) is a radiotherapeutic modality where a beta-emitting radionuclide is administered locally by intra-articular injection on the form of a colloid or radiolabeled particulate. RSV is a well-accepted therapeutic procedure in inflammatory joint diseases and has been successfully employed for more than 50 years as a viable alternative to surgical and chemical synovectomy. The aim of this work is to compare the in vivo stability of hydroxyapatite labelled with (177)Lu, (90)Y and (153)Sm. All radionuclides were labelled with high yield and were retained in the joint for 7 days, showing stability and usefulness as tools in the RSV treatment. A similar retention of the products in the muscle was observed when the particles were administrated in the muscle. However, the pure form of the radionuclides were rapidly cleared from the blood and accumulated in the liver when injected i.v.. Although (153)Sm-HA is already available for nuclear medicine procedures and clinical studies with (90)Y-HA have been developed, (177)Lu-labeled RSV agents will be economically more viable and has not been studied yet. Its favorable characteristics contribute to follow, to predict and asses the success of RSV by bone scintigraphy studies.
Asunto(s)
Durapatita/química , Inyecciones Intraarticulares/métodos , Animales , Partículas beta , Coloides/química , Rayos gamma , Miembro Posterior/diagnóstico por imagen , Inflamación , Lutecio/química , Tamaño de la Partícula , Radioisótopos/química , Cintigrafía , Ratas , Ratas Wistar , Samario/química , Distribución Tisular , Imagen de Cuerpo Entero , Radioisótopos de Itrio/químicaRESUMEN
Synthetic somatostatin (SST) analogues have been used in the preparation of receptor-specific radiopharmaceuticals for diagnostic and therapy of neuroendocrine tumors. This work studied the labeling conditions with (99m)Tc and biological distribution in Swiss mice of two SST analogs (HYNIC-Tyr(3)-Octreotide and HYNIC-Tyr(3)-Octreotate) and compared the biodistribution pattern with (111)In-DTPA-Octreotide. Biological distribution studies were performed after injection of radiopharmaceuticals on Swiss mice. Labeling procedures resulted on high radiochemical yield for all three preparations and the labeled products presented high in vitro stability. Biological distribution studies evidenced similar general biodistribution of (99m)Tc-labeled peptides when compared with indium-labeled peptide with fast blood clearance and elimination by urinary tract. Kidneys uptake of (99m)Tc-HYNIC-TATE are similar to (111)In-DTPA-Octreotide, and both are significantly higher than (99m)Tc-HYNIC-OCT. All labeled peptides presented similar uptake on liver, but the retention in time at intestines, particularly at large intestine, was more expressive for (111)In-labeled peptide. The %ID of (99m)Tc-HYNIC-OCT and (99m)Tc-HYNIC-TATE in organs with high density of SST receptors like pancreas and adrenals were significant and similar to obtained for (111)In-DTPA-Octreotide, confirming the affinity of these radiopharmaceuticals for the receptors.
Asunto(s)
Ácido Pentético/análogos & derivados , Somatostatina/química , Tecnecio/farmacocinética , Animales , Intestinos/diagnóstico por imagen , Riñón/efectos de los fármacos , Ligandos , Hígado/diagnóstico por imagen , Hígado/efectos de los fármacos , Ratones , Tumores Neuroendocrinos/diagnóstico por imagen , Octreótido/química , Ácido Pentético/farmacocinética , Péptidos/química , Control de Calidad , Cintigrafía , Radiofármacos/química , Factores de Tiempo , Distribución TisularRESUMEN
This work analysed the influence of the chelating group and radioligand on somatostatin analogues in vivo and in vitro properties. The presence of DOTA in the radioiodinated peptide produced a labeled analogue with similar blood kinetics and biodistribution to (177)Lu-DOTATATE and with lower abdominal uptake than (131)I-TATE. In addition, (131)I-DOTATATE showed significative tumour uptake, despite not so persistent after 24h. (131)I-DOTATATE can represent a cost-effective alternative to lutetium labeled peptide for neuroendocrine tumours therapy.
Asunto(s)
Radioisótopos de Yodo , Lutecio , Tumores Neuroendocrinos/diagnóstico por imagen , Radioisótopos , Somatostatina/análogos & derivados , Animales , Quelantes , Compuestos Heterocíclicos con 1 Anillo , Ratones , Tumores Neuroendocrinos/radioterapia , Farmacocinética , Cintigrafía , Radiofármacos/farmacocinética , Somatostatina/farmacocinética , Distribución TisularRESUMEN
The multiple scattering of coherent surface acoustic wave packets in a microstructure is studied using an ultrafast optical technique. By recording a set of acoustic transfer functions, we show that it is possible to implement time-reversal acoustics and refocus the wave packets up to the GHz range, two orders of magnitude higher than usual. Many applications in time-reversal acoustics are thus transposable to correspondingly smaller structures, opening the way to efficient nondestructive characterization and manipulation of multiple scattering on the microscale.
RESUMEN
The use of radiotracers allows the understanding of the bioavailability process, biodistribution, and kinetics of any molecule labelled with an isotope, which does not alter the molecule's biological properties. In this work, technetium-99m and iodine-125 were chosen as radiotracers for biodistribution studies in mice using bee (Apis mellifera) venom and a toxin (PnTX2-6) from the Brazilian "armed" spider (Phoneutria nigriventer) venom. Incorporated radioactivity was measured in the blood, brain, heart, lung, liver, kidney, adrenal gland, spleen, stomach, testicle, intestine, muscle, and thyroid gland. Results provided the blood kinetic parameter, and different organs distribution rates.(AU)
Asunto(s)
Animales , Venenos de Araña , Venenos de Abeja , AbejasRESUMEN
The preparation of N-succinimidyl-4-[131I]iodobenzoate (SIB) has been optimized using an alternative technique employing Cu(I)-assisted radioiododebromination that produces p-[131I]iodobenzoic acid. The reaction conditions were optimized and radiochemical purity of more than 90% was obtained when using 160 degrees C, 60 min reaction time and a [CuCl]/[p-bromobenzoic acid] relation of about 10(-2). After purification, the p-[131I]iodobenzoic acid reacted with TSTU to produce the SIB in a radiochemical yield greater than 98%. Protein conjugation using SIB resulted in a relatively low radiochemical yield. Biological distribution studies evidenced the in vivo stability of the labeled protein.
Asunto(s)
Radioisótopos de Yodo/química , Yodobenzoatos/síntesis química , Marcaje Isotópico/métodos , Proteínas/síntesis química , Radiofármacos/síntesis química , Cromatografía Líquida de Alta Presión/métodos , Radioisótopos de Yodo/aislamiento & purificación , Yodobenzoatos/química , Yodobenzoatos/aislamiento & purificación , Ligandos , Proteínas/química , Proteínas/aislamiento & purificación , Control de Calidad , Radiofármacos/química , Radiofármacos/aislamiento & purificación , TemperaturaRESUMEN
Radiolabelled peptides can provide new approaches for radiopharmaceutical development. Several prosthetic groups have been developed for radioiodination of proteins in order to minimize in vivo dehalogenation. In this work, the prosthetic group N-succinimidyl 4-[131I]iodobenzoate ([131I]SIB) was obtained by an alternative procedure that employs Cu(I) assisted radioiododebromination to produce p-[131I]iodobenzoic acid with a radiochemical yield of 92.73 +/- 1.51% (N = 6), followed by the reaction with TSTU (O-(N-succinimidyl)-N,N,N'N'-tetramethyluronium) in alkaline medium. The HPLC profile of the final product, revealed that [131I]SIB was obtained with a radiochemical purity of 98.19 +/- 1.14% (N = 6 Swiss mices (normal group) and animals with inflammation focus developed on the right thigh by tupertine injection) were injected with human immunoglobulin (IgG) radioiodinated with [131I]SIB and by direct method (Iodogen). The comparison of results showed a fast blood clearance, better target organ/background relation and low uptake in thyroid and stomach (p < 0.01) for the protein labelled with [131I]SIB, what suggests a greater in vivo stability.
Asunto(s)
Radioisótopos de Yodo/química , Proteínas/química , Radiofármacos/química , Animales , Humanos , Inmunoglobulina G/química , Inmunoglobulina G/aislamiento & purificación , Inflamación/diagnóstico por imagen , Radioisótopos de Yodo/aislamiento & purificación , Yodobenzoatos , Ratones , Proteínas/aislamiento & purificación , Cintigrafía , Radiofármacos/aislamiento & purificación , Distribución TisularRESUMEN
131I-STEVIOSIDE (1.10 MBq) was injected i.v in Wistar male rats, in distribution in the body and metabolism were studied. The highest concentration of radioactivity was observed in the liver and in the small intestine after 10 and 120 minutes, respectively. At 2 h after injection, the radioactivity eliminated in the bile was 52.0% of the original dose. The results of RP-HPLC analysis of the bile showed that stevioside was degraded in vivo and that steviol appeared as a major metabolite. However, in the urine; RP-HPLC analysis did not show the presence of steviol.